Board of Directors
Prof Dr Erich Platzer / Chairman
Prof Dr Erich Platzer, MD, is an Investment Advisor at HBM BioVentures AG. Previously, he has been Head of Oncology at Roche, Switzerland. Dr Platzer has over 10 years of operating experience in product development and marketing and has been responsible for various strategic corporate partnerships. .... more
Dr Dinnies von der Osten / Vice Chairman
Dr Dinnies von der Osten is CEO and partner of recently founded Goodvent Beteiligungsmanagement GmbH & Co.KG (“Goodvent”), a funds managing company specializing in early stage and growth financing of technology based companies. Prior to Goodventhe acted as CEO of IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH from 1998 until mid 2007. IBG funds, now managed by Goodvent, invest in early stage financing of technology oriented companies, especially in life sciences including biotechnology, nanotechnology, advanced materials, mechanical engineering and … more
Prof Dr Georg Frank
Prof Dr Georg Frank is currently engaged in several positions including as a consultant in the biotech industry. He has been the Managing Director of Bayer Bitterfeld GmbH. Prior to this he had several Executive Management positions at Bayer AG in Germany and in the US including Director R & D and Director Strategic Development of the Self Medication Division. He received a Masters Degree in Biology and a PhD in Chemistry and is a Honorary Professor in Chemistry at the University of … more
Dr Olivier Litzka
Dr Olivier Litzka, Edmond de Rothschild Investment Partners
Dr Jörg Neermann
Jörg Neermann, PhD, joined LSP as a Partner in the Munich Office in early 2007 and serves as member of the supervisory board of Affimed Therapeutics (D), Vivendy (CH) and Curetis (D) and Probiodrug (D). ....more
Dr Axel Polack
Dr Axel Polack joined TVM Capital in 2000, and is a General Partner for life sciences in the firm's Munich office. He is a member of the Board of Directors of Noxxon Pharma AG (Berlin, Germany) and Genetix Pharmaceuticals, Inc. (Cambridge, MA), and Invendo Medical (Kissing, Germany). He also represents the interests of TVM Capital with f-star and Probiodrug AG. … more
Dallas Webb
Dallas Webb, a portfolio manager of BB Biotech AG, joined Bellevue Asset Management in August 2006. BB Biotech is long term focused investment company that acquires holdings in biotechnology companies focused on the development of innovative medicines. BB Biotech is one of the world’s largest investors specialized in the biotechnology sector, and is listed on the stock exchanges in Switzerland, Germany and Italy. Prior to joining the BB Biotech team, Dallas ... more